Some Properties of Plesiomonas shigelloides Treated with Aminoglycosides

Folia Microbiologica

Volumn 48, Issue 5, 2003, Pages 659-663

  Hostacka A ^a   Ciznar I ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); PLESIOMONAS SHIGELLOIDES;

EID: 0346936500     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02993475     Document Type: Article

References (42)

1. ALDOVÁ E., SCHUBERT R.H.W.: Serotyping of Plesiomonas shigelloides: a tool for understanding of ecological relationship. Med. Microbiol.Lett. 5, 33-39 (1996).
2. AMPOFO K., GRAHAM P., RATNER A., RAJAGOPALAN L., DELLA-LATTA P., SAIMAN L.: Plesiomonas shigelloides sepsis and splenic abscess in an adolescent with sickle-cell disease. Pediatr.Infect.Dis.J. 20, 1178-1179 (2001).
3. ARAI T., IKEJIMA N., ITOH T., SAKAI S., SHIMADA T., SAKAZAKI R.: A survey of Plesiomonas shigelloides from aquatic environments, domestic animals, pets and humans. J.Hyg. 84, 203-211 (1980).
4. AVISON M.B., BENNETT P.M., WALSH T.R.: β-Lactamase expression in Plesiomonas shigelloides. J. Antimicrob.Chemother. 45, 877-880 (2000).
5. BARDON J.: Plesiomonas shigelloides and its serovars in animals in the Czech Republic - region Moravia. Centr.Eur.J.Publ.Health 7, 47-49 (1999).
6. BRAGA P.C., DAL SASSO M.: Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence. J.Antimicrob.Chemother. 45, 15-25 (2000).
7. BRENDEN R.A., MILLER M.A., JANDA J.M.: Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans. Rev.Infect.Dis. 10, 303-316 (1988).
8. CLARK R.B., LISTER P.D., ARNESON-ROTERT L., JANDA J.M.: In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotic - β-lactamase-inhibitor combinations. Antimicrob.Agents Chemother. 34, 159-160 (1990).
9. CLARK R.B., JANDA J.M.: Plesiomonas and human disease. Clin. Microbiol.Newslett. 13, 49-52 (1991)
10. DRAKE D., MONTIE T.C.: Flagella, motility and invasive virulence of Pseudomonas aeruginosa. J.Gen.Microbiol. 134, 43-52 (1988).
11. GORTA., IMLAY J.A.: Balance between endogenous superoxide stress and antioxidant defences. J.Bacteriol. 180, 1402-1410 (1998).
12. GRIMWOOD K., TO M., RABIN H.R., WOODS E.D.: Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob.Agents Chemother. 33, 41-47 (1989).
13. HASSETT D.J., SCHWEIZER H.P., OHMAN D.E.: Pseudomonas aeruginosa sodA and sodB mutants defective in manganese-and iron-cofactored superoxide dismutase activity demonstrate the importance of the iron-cofactored form in aerobic metabolism. J.Bacteriol. 177, 6330-6337 (1995).
14. HOŠTACKÁ A.: Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones. Microbios 91, 137-143 (1997).
15. HOŠTACKÁ A.: The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains. Folia Microbiol. 45, 387-390 (2000).
16. JANDA J.M., ABBOTT S.L.: Expression of hemolytic activity by Plesiomonas shigelloides. J.Clin.Microbiol. 31, 1206-1208 (1993).
17. KHARDORI N., FAINSTEIN V.: Aeromonas and Plesiomonas etiological agents. Ann.Rev.Microbiol. 42, 395-419 (1988).
18. KŘOVÁČEK K., ERIKSSON L.M., GONZALES-REY C., ROSINSKÝ J., ČIŽNÁR I.: Isolation, biochemical and serological characterization of Plesiomonas shigelloides from freshwater in Northern Europe. Comp.Immun.Microbiol.Infect.Dis. 23, 45-51 (2000).
19. KUSSER W.C., ISHIGURO E.E.: Effects of aminoglycosides and spectinomycin in the synthesis and release of lipopolysaccharide by Echerichia coli. Antimicrob.Agents Chemother. 32, 1247-1251 (1988).
20. LATRACHE H., BOURLIOUX P., KARROUA M., ZAHIR H., HAKKOU A.: Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli. Folia Microbiol. 45, 485-490 (2000).
21. LONON M.K., WOODS D.E., STRAUS D.: Production of lipase by clinical isolates of Pseudomonas cepacia. J.Clin.Microbiol. 26, 979-984 (1988).
22. MAJTÁN V., MAJTÁNOVÁ L'.: Influence on Enterobacter cloacae metabolism, cell-surface hydrophobicity and motility of suprainhibitory concentrations of carbapenems. Folia Microbiol. 46, 505-510 (2001).
23. MATTHEWS B.G., DOUGLAS H., GUINEY D.G.: Production of heat-stable enterotoxin by Plesiomonas shigelloides. Microb.Pathogenesis 5, 207-213 (1988).
24. MOLINARI G., GUZMÁN C.A., PESCE A., SCHITO G.C.: Inhibiton of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J.Antimicrob.Chemother. 31, 681-688 (1993).
25. QADRI F., HOSSAIN S.A., ČIŽNÁR I., HAIDER K., LJUNG A., WADSTRÖM T., SACK D.A.: Congo red binding and salt aggregation as indicators of virulence in Shigella species. J.Clin.Microbiol. 26, 1343-1348 (1988).
26. RAUTELIN H., SIVONEN A., KUIKKA O.V., VALTONEN V., KOSUNEN T.V.: Enteric Plesiomonas shigelloides infections in Finnish patients. Scand.Infect.Dis. 27, 495-498 (1995).
27. RAVN L., CHRISTENSEN A.B., MOLIN S., GIVSKOV M., GRAM L.: Methods for detecting acylated homoserine lactones produced by Gram-negative bacteria and their application in studies of AHL-production kinetics. J.Microbiol.Meth. 44, 239-251 (2001).
28. ROSENBERG M., GUTNICK D., ROSENBERG E.: Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiol.Lett. 9, 29-33 (1980).
29. SAVOIA D., RICATTO I., CAVALLO R., MILLESIMO M.: Aspecific adherence and cytotoxicity of Escherichia coli strains. Microbios 87, 21-30 (1996).
30. SEARS C.L., KAPER J.B.: Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microb.Rev. 60, 167-215 (1996).
31. SHIGEMATSU M., KAUFMANN M.E., CHARLETT A., NIHO Y., PITT T.L.: An epidemiological study of Plesiomonas shigelloides diarrhea among Japanese travellers. Epidemiol.Infectol. 125, 523-530 (2000).
32. SIGLER K., CHALOUPKA J., BROZMANOVA J., STADLER N., HÖFER M.: Oxidative stress in microorganisms - I. Microbial vs. higher cells - damage and defenses in relation to cell aging and death. Folia Microbiol. 44, 587-623 (1999).
33. STOCK I., WIEDEMANN B.: Natural antimicrobial susceptibilities of Plesiomonas shigelloides strains. J.Antimicrob.Chemother. 48, 803-811 (2001).
34. STORZ G., IMLAY J.A.: Oxidative stress. Curr.Opin.Microbiol. 2, 188-194 (1999).
35. SWIFT S., WILLIAMS P., STEWART G.S.A.B.: N-Acylhomoserine lactones and quorum sensing in proteobacteria, pp. 291-313 in Cell-Cell Signalling in Bacteria (G.M. Dunny, S. Winans, Eds). American Society for Microbiology, Washington (DC) 1999.
36. TATEDA K., HIRAKATA Y., FURUYA N., OHNO A., YAMAGUCHI K.: Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa. Antimicrob.Agents Chemother. 37, 675-681 (1993).
37. TATEDA K., YOSHIKAZU I., HIRAKATA Y., MATSUMOTO T., OHNO A., YAMAGUCHI K.: Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. J.Antimicrob.Chemother. 34, 931-942 (1994).
38. THEODOROPOULOS C., WONG T.H., O'BRIEN M., STENZEL D.: Plesiomonas shigelloides enters polarized human intestinal Caco-2 cells in an in vitro model system. Infect.Immun. 69, 2260-2269 (2001).
39. TIRUNARAYANAN M.O., LUNDBECK H.: Investigations on the enzymes and toxins of staphylococci. Acta Pathol.Microbiol.Scand. 72, 263-276 (1968).
40. TSENG H.K., LIU C.P., LI W.C., SU S.C., LEE C.M.: Characteristics of Plesiomonas shigelloides infections in Taiwan. J.Microbiol. Immunol.Infectol. 35, 47-52 (2002).
41. VÍTOVEC J., ALDOVÁ E., VLADÍK P., KŘOVÁČ EK K.: Enteropathogenicity of Plesiomonas shigelloides and Aeromonas spp. in experimental mono-and co-infection with Cryptosporidium parvum in the intestine of neonatal BALB/c mice. Comp.Immunol. Microbiol.Infect.Dis. 24, 39-55 (2001).
42. WONG T.Y., TSUI H.Y., SO M.K., LAI J.Y., LAI ST., TSE C.W., NG T.K.: Plesiomonas shigelloides infection in Hong Kong: retrospective study of 167 laboratory-confirmed cases. Hong Kong Med. J. 6, 375-380 (2000).